IDARUCIZUMAB vs IFOSFAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDARUCIZUMAB vs IFOSFAMIDE: Safety Overview
| Metric | IDARUCIZUMAB | IFOSFAMIDE |
|---|---|---|
| Total FAERS Reports | 1,562 | 17,004 |
| Deaths Reported | 1,014 | 3,365 |
| Death Rate | 64.9% | 19.8% |
| Hospitalizations | 570 | 5,230 |
| Average Patient Age | 77.6 yrs | 36.2 yrs |
| % Female Patients | 42.7% | 41.7% |
| FDA Approval Date | N/A | Apr 4, 2007 |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | Baxter Healthcare Corporation |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |